Corticosteroid response predicts success of laparoscopic splenectomy in treating immune thrombocytopenia☆

[1]  J. González-Porras,et al.  Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines , 2016, Annals of Hematology.

[2]  F. Brunkhorst,et al.  Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  E. Panieri,et al.  Role of splenectomy for immune thrombocytopenic purpura (ITP) in the era of new second-line therapies and in the setting of a high prevalence of HIV-associated ITP. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[4]  S. T. Mees,et al.  Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): a retrospective cohort study on longtime response predicting factors based on consensus criteria. , 2014, International journal of surgery.

[5]  W. Schaffner,et al.  Clinical practice. Care of the asplenic patient. , 2014, The New England journal of medicine.

[6]  MontalvoJorge,et al.  Laparoscopic Splenectomy for Primary Immune Thrombocytopenia: Clinical Outcome and Prognostic Factors , 2014 .

[7]  Xubao Liu,et al.  Should We Routinely Transfuse Platelet for Immune Thrombocytopenia Patients with Platelet Count Less Than 10 × 109/L Who Underwent Laparoscopic Splenectomy? , 2014, World Journal of Surgery.

[8]  J. González-Porras,et al.  Safety and efficacy of splenectomy in over 65‐yrs‐old patients with immune thrombocytopenia , 2013, European journal of haematology.

[9]  J. Bussel,et al.  Long‐term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy , 2013, British journal of haematology.

[10]  J. Rossi,et al.  Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta‐analysis , 2012, British journal of haematology.

[11]  D. Cook,et al.  A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. , 2012, Blood.

[12]  G. Corazza,et al.  Post-splenectomy and hyposplenic states , 2011, The Lancet.

[13]  M. Crowther,et al.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. , 2011, Blood.

[14]  A. Mickevičius,et al.  Prognostic factors for positive immune thrombocytopenic purpura outcome after laparoscopic splenectomy , 2011 .

[15]  C. Kessler,et al.  Short‐term and long‐term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: A systematic review , 2009, American journal of hematology.

[16]  S. Fortuna,et al.  Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature , 2008, Haematologica.

[17]  F. Dentali,et al.  Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura , 2007, Annals of Internal Medicine.

[18]  I. Gich,et al.  Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura , 2006, Surgical Endoscopy And Other Interventional Techniques.

[19]  Hyo-jin Kim,et al.  Prognostic Factors of Response to Laparoscopic Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura , 2005, Journal of Korean medical science.

[20]  S. Vesely,et al.  Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. , 2004, Blood.

[21]  M. Rosen,et al.  Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. , 2004, Archives of surgery.

[22]  C. Schlachta,et al.  Laparoscopic splenectomy for idiopathic thrombocytopenic purpura (ITP) , 2002, Surgical Endoscopy And Other Interventional Techniques.